Literature DB >> 29802374

Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.

Zhi-Lei Zhang1, Guang-Chao Liu1, Li Peng2, Chong Zhang1, Yu-Ming Jia1, Wu-Han Yang1, Lei Mao1.   

Abstract

This study intends to explore the effect of the PAK1 gene silencing on apoptosis and proliferation of hepatocellular carcinoma (HCC) MHCC97-H and HepG2 cells and cells in xenograft tumor. MHCC97-H and HepG2 cells and mice with xenograft tumor in vivo were randomly divided into control, empty vector and PAK1 shRNA groups. Morphology and the expression of green fluorescent protein of MHCC97-H and HepG2 cells and cells in xenograft tumor were observed. MTT assay and flow cytometry were used to detect proliferation, cell cycle and apoptosis of MHCC97-H and HepG2 cells and cells in xenograft tumor. The expressions of PAK1, PCNA, Ki67, Cyclin E, CDK2, p21, p53, Bax and Bcl-2 were measured using the quantitative reverse transcription polymerase chain reaction and western blotting. Compared with the control and empty vector groups, number of adherent cells of MHCC97-H and HepG2 cells and cells in xenograft tumor was reduced, and green fluorescent cells became round and reduced in the PAK1 shRNA group. Cell proliferation, the cells at S phase, the mRNA and protein expressions of PAK1, PCNA, Ki67, Cyclin E, CDK2 and Bcl-2 of MHCC97-H and HepG2 cells and cells in xenograft tumor were decreased, while the cells at G1 phase, apoptosis rate, the mRNA and protein expressions of p21, p53 and Bax of MHCC97-H and HepG2 cells and cells in xenograft tumor were increased in the PAK1 shRNA group. PAK1 gene silencing decreases proliferation of MHCC97-H cells, HepG2 cells and cells in xenograft tumor through the p53/p21 pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29802374     DOI: 10.1038/s41434-018-0016-9

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

1.  Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.

Authors:  Long Fang; Chun Gao; Ru-Xue Bai; Hui-Fen Wang; Shi-Yu Du
Journal:  Cancer Gene Ther       Date:  2020-09-26       Impact factor: 5.987

2.  Antiproliferative and apoptotic potential of Glycyrrhizin against HPV16+ Caski cervical cancer cells: A plausible association with downreguation of HPV E6 and E7 oncogenes and Notch signaling pathway.

Authors:  Afza Ahmad; Rohit Kumar Tiwari; Prakriti Mishra; Ali G Alkhathami; Tahani M Almeleebia; Mohammad Y Alshahrani; Irfan Ahmad; Rawan Amer Asiri; Noura M Alabdullah; Mohamed Hussien; Mohd Saeed; Irfan Ahmad Ansari
Journal:  Saudi J Biol Sci       Date:  2022-01-31       Impact factor: 4.052

3.  The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors.

Authors:  Marc Micó-Carnero; Araní Casillas-Ramírez; Alfredo Sánchez-González; Carlos Rojano-Alfonso; Carmen Peralta
Journal:  Biomedicines       Date:  2022-04-23

4.  Numb inhibits cell proliferation, invasion, and epithelial-mesenchymal transition through PAK1/β-catenin signaling pathway in ovarian cancer.

Authors:  Jiabin Liang; Bingbing Han; Yunhe Zhang; Qingfen Yue
Journal:  Onco Targets Ther       Date:  2019-04-29       Impact factor: 4.147

5.  Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells.

Authors:  Madhumitha Kedhari Sundaram; Sreepoorna Unni; Pallavi Somvanshi; Tulika Bhardwaj; Raju K Mandal; Arif Hussain; Shafiul Haque
Journal:  Genes (Basel)       Date:  2019-11-21       Impact factor: 4.096

6.  Targeting of p21-Activated Kinase 4 Radiosensitizes Glioblastoma Cells via Impaired DNA Repair.

Authors:  Leon J Blankenstein; Nils Cordes; Leoni A Kunz-Schughart; Anne Vehlow
Journal:  Cells       Date:  2022-07-06       Impact factor: 7.666

7.  Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer.

Authors:  Dahong Yao; Jian Huang; Jinhui Wang; Zhendan He; Jin Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.